Skip to main content
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Apr 28, 2026, 4:00 PM EDT
2.160
-0.040 (-1.82%)
After-hours: Apr 28, 2026, 6:30 PM EDT

Century Therapeutics Revenue

In the year 2025, Century Therapeutics had annual revenue of $109.16M with 1,556.76% growth.

Revenue (ttm)
$109.16M
Revenue Growth
+1,556.76%
P/S Ratio
3.63
Revenue / Employee
$1,399,538
Employees
78
Market Cap
396.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025109.16M102.58M1,556.76%
Dec 31, 20246.59M4.35M194.81%
Dec 31, 20232.24M-2.96M-57.01%
Dec 31, 20225.20M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
Niagen Bioscience 129.42M
Enanta Pharmaceuticals 66.98M
Invivyd 53.43M
Lineage Cell Therapeutics 14.56M
PureTech Health 6.39M
YD Bio 510.36K
vTv Therapeutics 17.00K
Revenue Rankings

IPSC News

More News